Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Background/aimsFemale choroideremia carriers present with a spectrum of disease severity. Unlike in men, the rate of disease progression has not been well characterised in carriers. This longitudinal study aimed to determine the rate of retinal degeneration in choroideremia carriers, using multimodal imaging and microperimetry.MethodsChoroideremia carriers previously seen at Oxford Eye Hospital (United Kingdom) between 2012 and 2017 returned for testing between 2015 and 2023, providing up to 11 years’ follow-up data. Participants had optical coherence tomography, fundus-tracked microperimetry and fundus autofluorescence (FAF) imaging performed.ResultsThirty-four eyes of 17 choroideremia carriers were examined using multimodal imaging. Median age was 44 (range: 15–73) years at baseline and median follow-up duration was 7 (range: 1–11) years. At baseline, phenotype was classified as fine (n=5 eyes), coarse (n=13 eyes), geographic (n=12 eyes) or male pattern (n=4 eyes). Thirteen patients showed no change in phenotype classification, four showed slight changes associated with choroideremia-related retinal degeneration. Despite this, carriers with severe retinal phenotypes had a statistically significant decline in average retinal sensitivity (−0.7 dB and −0.8 dB per year, respectively, p<0.001), area of geographic loss defined by FAF (+2.5 mm2and +3.7 mm2per year, respectively, p<0.001) and thinning of the photoreceptor complex (up to −2.8 microns and −10.3 microns per year, p<0.001).ConclusionChoroideremia carriers, particularly those with severe retinal phenotypes, exhibit progressive retinal degeneration, as evident by multimodal imaging biomarkers and functional testing. Clinicians should not rely on retinal severity classification alone to assess disease progression.

Original publication

DOI

10.1136/bjo-2024-325578

Type

Journal article

Journal

British Journal of Ophthalmology

Publisher

BMJ

Publication Date

09/08/2024